brigatinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (2)

Interventional (2)

Fundación GECP (1)
Scott R. Plotkin, MD, PhD (1)

No (2)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadchemo-radiotherapy

I am/have/hadconventional imaging

I am/have/hadneurofibroma

I am/have/hadadjuvant chemotherapy

I am/have/hadliquid biopsy

I am/have/hadunstable angina

I am/have/hadbone metastases

I am/have/hadhepatitis

I am/have/hadneutrophil count

I am/have/hadbilateral tubal ligation

I am/have/hadlipase

I am/have/hadsecondary malignant neoplasm of liver

I am/have/hadnf2 gene

I am/have/hadserum bilirubin

I am/have/hadserum pregnancy test

I am/have/hadmeasurable disease

I am/have/hadintrauterine device (iud)

I am/have/hadcancer

I am/have/hadmalabsorption

I am/have/hadglioma

added new label for I am/have/had

more

I am looking for

I am looking forlipase

I am looking forcolony stimulating factor

I am looking forbrigatinib

I am looking foradjuvant

I am looking forinvestigational drug

I am looking forg-csf

I am looking forprobe

I am looking forhepatitis b

I am looking forhepatitis b surface antigen

I am looking forexperimental drug

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients

Chemotherapy-nave patients with EML4-ALK rearrangement and with locally advanced or metastatic non-small cell lung cancer patients will be selected. Patients enrolled in the study will receive brigatinib 90mg for the first 7 days (D 1-7 at cycle 1) and then 180mg daily thereafter for QW4 cycles of duration (28 days …

chemo-radiotherapy

blood transfusion

unstable angina

liquid biopsy

adjuvant chemotherapy

0 views
19 Feb, 2024

Phase 2
For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Neurology
Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2

Embedded within the Master Study are individual drug substudies. Investigational Drug Sub-study A: Brigatinib

conventional imaging

neurofibroma

experimental therapy

meningiomatosis

cataract

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.